US 11964047
Ophthalmic formulations and related methods
granted A61KA61K47/24A61K47/26
Quick answer
US patent 11964047 (Ophthalmic formulations and related methods) held by ETERNATEAR, INC. expires Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ETERNATEAR, INC.
- Grant date
- Tue Apr 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K47/24, A61K47/26, A61K47/44, A61K9/0048